Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination.
about
Influenza vaccination in HIV-positive subjects: latest evidence and future perspectiveLong-term follow-up in patients with HIV vaccinated with pandemic influenza A(H1N1)/09 AS03-adjuvanted split virion vaccine and seasonal trivalent influenza split virion vaccineImmunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.HIV virological suppression influences response to the AS03-adjuvanted monovalent pandemic influenza A H1N1 vaccine in HIV-infected childrenHigh level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccine.Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccineInfluenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literaturePandemic Influenza A (H1N1) Infection among HIV-Infected Adults in France.Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adults.Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.H1N1pdm09 adjuvanted vaccination in HIV-infected adults: a randomized trial of two single versus two double doses.Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults.The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adultsUpregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy.Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patientsRandomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand.Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected childrenRespiratory infection complicating HIV infectionA review of influenza vaccine immunogenicity and efficacy in HIV-infected adultsSafety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccineInfluenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responsesDuration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010-2011.Influenza A H1N1 in HIV-infected adults.Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey.Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore.Immunization of HIV-infected adult patients - French recommendations.Sometimes, more is better.Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adults.Pulmonary manifestation of novel swine-origin influenza A (H1N1) virus (S-OIV) infection in immunocompromised patients: initial findings with multidetector computed tomography.
P2860
Q27007483-A5A90738-9B0A-479B-B085-C3BFAAB65456Q30353329-00FAD8D9-FEC1-46C8-97A6-236D461B25C2Q30357158-BC9BF017-8A84-4801-89F9-80D67E56EF00Q30359207-93A46CA0-3EB6-4AC0-A1F0-B73AC113979CQ30362521-19FF0220-2020-4F9F-BA56-9F6D147EC6C9Q30366119-34727C68-4171-4EE6-80E1-ED8C7AA6069AQ30373691-780C74C1-648A-4C81-A67C-531E03DD8DE5Q30399278-8B89DFDE-1B09-49BC-8BA1-A86741773200Q30402599-6126C14B-8695-442F-A067-82318EF62724Q30404293-15CA1DE9-110B-4025-96CB-7EE190302087Q30412595-0499C74A-BFB6-4684-B73F-7CF8498AD0CEQ30414543-9C31534F-8C18-461D-9BC1-04FE4E134531Q30418834-4718EB0E-BF04-4619-B873-6A8EB09EC72DQ33879545-E764FB63-6804-4018-BF2E-6C86EA9FDFE5Q34097791-02E71E1C-D7D4-4CED-991F-4663D1F81D53Q34699094-2A2B255C-2409-4EA9-AC3F-27AE054F6090Q35207950-CDD71B9F-9CC4-4AC8-8B85-229457E6732BQ35589557-B7BA3199-F997-4CBA-B963-62787C9013B8Q36447589-0742C931-7F85-4B91-B870-7F863DF693ECQ37040671-491F9AC7-D19C-4D36-BC55-5D7AD7327CDCQ37085842-C7F1F62E-D055-4588-A2F9-C7E0F9533FD8Q37145744-208CBF9F-26C3-4AE9-BA4D-422803F0B2E2Q37309289-23D21C09-0196-4C1B-AF7D-84ADB2DE1C0CQ37416103-BFFF89FB-9433-4F9F-BEF5-5BBDB49A7AEEQ37523349-832E0FEF-3A89-412C-8567-CF1665BE67E3Q38440755-6ED39CC8-1B7B-4A89-A944-DCFFB36F74F9Q39051028-C93C33A4-3E52-454E-A481-9E489D2E3E85Q40300395-21884008-64BE-4BB1-9FB7-3A44F4777437Q40615516-6F8DA5DA-B4CA-4A10-8F69-2433E0BF235BQ42788819-40123C4C-3118-433F-B4D9-82C6EBFA0822Q44420213-699C0088-D093-4B18-902D-BE770E07AF1EQ45357079-3523FA0C-C945-4C68-9CB6-9D0BB02BF0CA
P2860
Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Influenzavirus infection is a ...... d adults, despite vaccination.
@en
type
label
Influenzavirus infection is a ...... d adults, despite vaccination.
@en
prefLabel
Influenzavirus infection is a ...... d adults, despite vaccination.
@en
P2093
P356
P1476
Influenzavirus infection is a ...... d adults, despite vaccination.
@en
P2093
Guy Boivin
Lina DelBalso
Marina B Klein
Stéphanie Coté
P304
P356
10.1086/518986
P407
P577
2007-06-12T00:00:00Z